Adaptive RAG-Assisted MRI Platform (ARAMP) for Brain Metastasis Detection and Reporting: A Retrospective Evaluation...

This study aimed to develop and evaluate an AI-driven platform, the Adaptive RAG Assistant MRI Platform (ARAMP), for assisting in the diagnosis and reporting of brain metastases using post-contrast axial T1-weighted (AX_T1+C) MRI. In this retrospective study, 2447 cancer patients who underwent MRI between 2010 and 2022 were screened. A subset of 100 randomized patients with confirmed brain metastases and 100 matched non-cancer controls were selected for evaluation. ARAMP integrates quantitative radiomic feature extraction with an adaptive Retrieval-Augmented Generation (RAG) framework based on a large language model (LLM, GPT-4o), incorporating five authoritative medical references. Three board-certified neuroradiologists and an independent LLM (Gemini 2.0 Pro) assessed ARAMP performance. Metrics of the assessment included Pre-/Post-Trained Inference Difference, Inter-Inference Agreement, and Sensitivity. Post-training, ARAMP achieved a mean Inference Similarity score of 67.45%. Inter-Inference Agreement among radiologists averaged 30.20% (p = 0.01). Sensitivity for brain metastasis detection improved from 0.84 (pre-training) to 0.98 (post-training). ARAMP also showed improved reliability in identifying brain metastases as the primary diagnosis post-RAG integration. This adaptive RAG-based framework may improve diagnostic efficiency and standardization in radiological workflows.